1Buy.AI | $3,900,000 | (Feb 3, 2026)
PranaX | $17,000,000 | (Feb 3, 2026)
DexMat | $5,000,000 | (Feb 3, 2026) Certified by Founder
Lodge
CHARM Therapeutics
start up
United Kingdom
- London
- 09/06/2022
- Series A
- $50,000,000
Harnessing the power of deep learning on 3D molecular configurations to deliver medicines of transformational efficacy to patients.
- Industry Research Services
- Website https://charmtx.com/
- LinkedIn https://www.linkedin.com/company/charm-therapeutics/
Related People
Laksh AithaniFounder
United Kingdom -
London, England,
Passionate about drug discovery and machine learning
Prenosis | $20,000,000 | (Feb 3, 2026)
CloudForge AI | $3,950,000 | (Feb 3, 2026)
Poetiq | $45,800,000 | (Feb 3, 2026)
BizTrip AI | $1,500,000 | (Feb 3, 2026)
Co-reactive | $7,754,157 | (Jan 30, 2026)
Arkero | $6,000,000 | (Jan 30, 2026)
Redwood Materials | $425,000,000 | (Jan 30, 2026)
Twogee Biotech | $2,575,886 | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)